Covington’s CTI, a biotech firm specializing in clinical research, was recently honored at the 11th annual Cincinnati Business Courier’s C-Suite Awards. Chief Operating Officer Jon Koch, Chief Financial Officer Brian Lawrence, and another Chief were recognized for their leadership, showcasing the firm’s contributions to the region’s thriving biotech sector.

Faricimab has demonstrated greater fluid reduction than high-dose aflibercept at 12 weeks, offering new hope for patients with diabetic macular edema and age-related macular degeneration. These findings could influence future treatment approaches for these common eye conditions.